TerrAscend (TSND.TO) Stock Analysis & Winston Score

TerrAscend is a cannabis company that grows, processes, and sells marijuana products for both medical patients and adult recreational users. Its products include cannabis flower, edibles, vapes, and concentrates, sold under brands like Gage Cannabis and The Apothecarium. The company operates licensed dispensaries and wholesale operations primarily in the United States and Canada. TerrAscend makes money by selling cannabis products directly to consumers through its own retail stores and by supplying licensed dispensaries as a wholesale producer. It operates mainly in U.S. states like New Jersey, Pennsylvania, Michigan, and Maryland, with a smaller Canadian presence, and generates roughly $200–250 million in annual revenue. The company's main competitive advantage is its multi-state operator licenses, which are difficult to obtain, but its deeply negative return on invested capital signals that profitability remains a serious challenge — and the biggest growth catalyst would be federal cannabis rescheduling in the U.S., which could open banking access and reduce the heavy tax burden the industry currently faces.